Indirect evidences of functionality of insulinoma on FDG‑PET: The ‘whole body‑metabolism’ advantage and its clinical implications.

Basu, S2016-02-162016-02-162015-01Basu S. Indirect evidences of functionality of insulinoma on FDG‑PET: The ‘whole body‑metabolism’ advantage and its clinical implications. Indian Journal of Cancer. 2015 Jan-Mar; 52(1): 68-69.0019-509Xhttp://imsear.searo.who.int/handle/123456789/173106enIndirect evidences of functionality of insulinoma on FDG‑PET: The ‘whole body‑metabolism’ advantage and its clinical implications.Article